Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Can Fam Physician ; 59(8): e357-63, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23946042

ABSTRACT

OBJECTIVE: To determine the experiences of family physicians in Newfoundland and Labrador with parents' use of natural health products (NHPs) for their children and to assess physicians' attitudes toward use of NHPs in children. DESIGN: A survey using the Dillman approach. SETTING: Newfoundland and Labrador. PARTICIPANTS: All family physicians in the province. MAIN OUTCOME MEASURES: Physician demographic characteristics; whether physicians inquire about the use of NHPs in children; the degree to which they think patients disclose use of NHPs in children; whether they counsel parents about the potential benefits or harms of NHPs; their own opinions about the usefulness of NHPs; whether they recommend NHPs in children and for what reasons; and the particular NHPs they have seen used in children and for what reasons. RESULTS: A total of 159 (33.1%) family physicians responded; 65.4% were men, 71.7% were Canadian medical graduates, and 46.5% practised in rural areas. Overall, 18.8% of family physicians said they regularly or frequently asked about NHP use; 24.7% counseled patients about potential harms. Only 1.9% of physicians believed NHPs were usually beneficial, but a similarly small number (8.4%) thought they were usually harmful. Most respondents were somewhat neutral; 59.7% said they never recommend NHPs for children, and a further 37.0% said they would only "sometimes" recommend NHPs. CONCLUSION: Most physicians believed that NHPs were probably of little benefit but not likely to be harmful. Most NHPs used were vitamins and minerals. Physicians recognized that NHPs were often used by parents for children, but in general they believed NHPs had little effect on their day-to-day medical practices. Thirty-eight (24.7%) of the 154 physicians had at least once recommended an NHP (including vitamins) for their pediatric patients. Physicians believed that parents did not often disclose use of NHPs for their children, but at the same time physicians generally did not actively inquire.


Subject(s)
Attitude of Health Personnel , Complementary Therapies/statistics & numerical data , Patient Education as Topic , Physicians, Family , Child , Complementary Therapies/adverse effects , Complementary Therapies/methods , Female , Humans , Male , Materia Medica/adverse effects , Materia Medica/therapeutic use , Minerals/adverse effects , Minerals/therapeutic use , Newfoundland and Labrador , Pediatrics/methods , Phytotherapy/adverse effects , Phytotherapy/methods , Phytotherapy/statistics & numerical data , Probiotics/adverse effects , Probiotics/therapeutic use , Surveys and Questionnaires , Vitamins/adverse effects , Vitamins/therapeutic use
2.
Vestn Oftalmol ; 127(5): 15-8, 2011.
Article in Russian | MEDLINE | ID: mdl-22165092

ABSTRACT

Methods of conservative and complex rehabilitation of patients with cicatricial eyelid malpositions are proposed. Conservative treatment included developed regimen of antihomotoxic agents, different techniques of graduated extension of scar tissues, special eyelid exercises. In complex management conservative treatment was provided along with surgery, in some cases botulinum toxin A was administered. Duration, time and priorities were determined.


Subject(s)
Blepharoplasty/methods , Botulinum Toxins, Type A , Cicatrix/therapy , Drug Therapy/methods , Eyelid Diseases/therapy , Eyelids/surgery , Minerals , Plant Extracts , Adolescent , Adult , Aged , Botulinum Toxins, Type A/administration & dosage , Botulinum Toxins, Type A/adverse effects , Cicatrix/complications , Cicatrix/pathology , Cicatrix/physiopathology , Combined Modality Therapy , Eyelid Diseases/etiology , Eyelid Diseases/physiopathology , Eyelids/physiopathology , Female , Humans , Male , Materia Medica/administration & dosage , Materia Medica/adverse effects , Middle Aged , Minerals/administration & dosage , Minerals/adverse effects , Neuromuscular Agents/administration & dosage , Neuromuscular Agents/adverse effects , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Treatment Outcome
3.
Cochrane Database Syst Rev ; (2): CD004845, 2009 Apr 15.
Article in English | MEDLINE | ID: mdl-19370613

ABSTRACT

BACKGROUND: Homeopathic medicines are used by patients with cancer, often alongside conventional treatment. Cancer treatments can cause considerable morbidity and one of the reasons patients use homeopathic medicines is to help with adverse effects. OBJECTIVES: Evaluate effectiveness and safety of homeopathic medicines used to prevent or treat adverse effects of cancer treatments. SEARCH STRATEGY: The following were searched up to November 2008: Cochrane PaPaS Trials Register; Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; EMBASE; CINAHL; BNI; CancerLIT; AMED; CISCOM; Hom-Inform; SIGLE; National Research Register; Zetoc; www.controlled-trials.com; http://clinicaltrials.gov; Liga Medicorum Homeopathica Internationalis (LMHI, Liga) conference proceedings; reference lists of relevant studies were checked; and homeopathic manufacturers, leading researchers and practitioners were contacted. SELECTION CRITERIA: Randomised controlled trials (RCTs) of homeopathic medicines in participants with a clinical or histological diagnosis of cancer where the intervention was aimed at preventing or treating symptoms associated with cancer treatments. All age groups, and all stages of disease were included. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed studies for inclusion and two review authors extracted data. Three review authors independently assessed trial quality using the Delphi List and the Cochrane Collaboration's tool for assessing risk of bias. Disagreements were resolved by consensus. Where available, data were extracted for analysis. MAIN RESULTS: Eight controlled trials (seven placebo controlled and one trial against an active treatment) with a total of 664 participants met the inclusion criteria. Three studied adverse effects of radiotherapy, three studied adverse effects of chemotherapy and two studied menopausal symptoms associated with breast cancer treatment.Two studies with low risk of bias demonstrated benefit: one with 254 participants demonstrated superiority of topical calendula over trolamine (a topical agent not containing corticosteroids) for prevention of radiotherapy-induced dermatitis, and another with 32 participants demonstrated superiority of Traumeel S (a proprietary complex homeopathic medicine) over placebo as a mouthwash for chemotherapy-induced stomatitis. Two other studies reported positive results, although the risk of bias was unclear, and four further studies reported negative results.No serious adverse effects or interactions were reported attributable to the homeopathic medicines used. AUTHORS' CONCLUSIONS: This review found preliminary data in support of the efficacy of topical calendula for prophylaxis of acute dermatitis during radiotherapy and Traumeel S mouthwash in the treatment of chemotherapy-induced stomatitis. These trials need replicating. There is no convincing evidence for the efficacy of homeopathic medicines for other adverse effects of cancer treatments. Further research is required.


Subject(s)
Antineoplastic Agents/adverse effects , Homeopathy/methods , Neoplasms/drug therapy , Neoplasms/radiotherapy , Radiation Injuries/therapy , Breast Neoplasms/therapy , Calendula/adverse effects , Female , Humans , Menopause , Minerals/adverse effects , Minerals/therapeutic use , Phytotherapy/adverse effects , Phytotherapy/methods , Plant Extracts/adverse effects , Plant Extracts/therapeutic use , Radiodermatitis/therapy , Randomized Controlled Trials as Topic , Stomatitis/therapy
4.
Drug Saf ; 17(5): 342-56, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9391777

ABSTRACT

Since 1991, the Medical Toxicology Unit (MTU) at Guys' Hospital, London, has been assessing the toxicological problems associated with the use of traditional and herbal remedies and dietary supplements. This assessment was carried out by evaluating reports to the National Poisons Information Service (London) [NPIS(L)] which provides emergency information to medical professionals. Relevant telephone enquiries to NPIS(L) were identified. Further case details were obtained by follow-up questionnaire, clinical consultation, toxicological analysis of samples from patients and/or products and botanical identification of plant material. Of 1297 symptomatic enquiries evaluated there was a possible/confirmed association in 785 cases. Case series have been identified which substantiate previous reports, including liver problems following the use of Chinese herbal medicine for skin disorders, allergic reactions to royal jelly and propolis and heavy metal poisoning caused by remedies from the Indian subcontinent. Although the overall risk to public health appears to be low, certain groups of traditional remedies have been associated with a number of potentially serious adverse effects. Considering the extent of use of herbal remedies and food supplements a comprehensive surveillance system for monitoring the adverse health effects of these products is essential. Surveillance of a large population is needed for the complex task of identifying the uncommon and unpredictable adverse effects which are potentially serious. In the UK, the Medicines Control Agency responded to the MTU report by recognising the need for vigilance and by incorporating adverse reactions reporting on unlicensed herbal remedies into their drug reaction monitoring function. As a further step to safeguard the patients/consumers an effective single regulatory system is required which would ensure the safety and quality of all herbal remedies and food supplements available in the UK.


Subject(s)
Dietary Supplements/adverse effects , Phytotherapy , Amino Acids/adverse effects , Central Nervous System Stimulants/adverse effects , Dietary Supplements/standards , Drug Hypersensitivity , Drug Interactions , Drugs, Chinese Herbal/adverse effects , Homeopathy , Humans , Medicine, Ayurvedic , Minerals/adverse effects , Plant Extracts/adverse effects , Vitamins/adverse effects
5.
Sports Med ; 44(7): 943-56, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24723211

ABSTRACT

BACKGROUND: Injection therapies are widely used for muscle injuries. As there is only limited evidence of their efficacy, physicians should be aware of the potential harmful effects of these injected preparations. OBJECTIVES: The purpose of this review was to systematically review the literature on the myotoxic effects of intramuscular injection preparations commonly used for acute muscle injuries. DATA SOURCES: The databases of PubMed, Embase, Web of Science, Cochrane Library, CINAHL and SportDiscus were searched in March 2013. STUDY ELIGIBILITY CRITERIA: Studies reporting histological evaluation or creatine kinase activity after intramuscular injection with local anaesthetics, corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), platelet-rich plasma (PRP), Traumeel(®) and Actovegin(®), or combination preparations were eligible for inclusion. DATA ANALYSIS: Two authors independently screened the search results and assessed the risk of bias. A best-evidence synthesis was used to identify the level of evidence. RESULTS: Forty-nine studies were included in this systematic review. There is strong to moderate evidence that intramuscularly injected local anaesthetics and NSAIDs are myotoxic, and there is conflicting evidence of the myotoxicity of PRP. There is limited evidence that single corticosteroid injections are not myotoxic but have a synergistic myotoxic effect when used together with local anaesthetics. There is no information to assess whether Actovegin(®) and Traumeel(®) are myotoxic. CONCLUSION: Local anaesthetics and NSAID injections are not recommended for the treatment of muscle injuries in athletes, as they are myotoxic. The possible myotoxic effects of corticosteroids, PRP, Traumeel(®) and Actovegin(®) should be assessed in future research.


Subject(s)
Anesthetics, Local/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Muscle, Skeletal/drug effects , Muscle, Skeletal/injuries , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/adverse effects , Anesthetics, Local/administration & dosage , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Creatine Kinase/metabolism , Heme/administration & dosage , Heme/adverse effects , Heme/analogs & derivatives , Homeopathy/adverse effects , Humans , Injections, Intramuscular , Minerals/administration & dosage , Minerals/adverse effects , Muscle, Skeletal/enzymology , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Platelet-Rich Plasma
6.
Arzneimittelforschung ; 55(1): 23-9, 2005.
Article in English | MEDLINE | ID: mdl-15727161

ABSTRACT

The increasing interest in alternative medical practices has led to a number of controlled studies on herbal and homeopathic agents. This paper presents the results of a meta-analysis of four recent clinical trials evaluating the homeopathic preparation Vertigoheel (VH) compared with usual therapies (betahistine, Ginkgo biloba extract, dimenhydrinate) for vertigo in a total of 1388 patients. Two trials were observational studies and the other two were randomised double-blind controlled trials. The duration of treatment (6-8 weeks) and dosage were comparable in all studies. Treatments were evaluated for the variables "number of vertigo episodes", "intensity of episodes" and "duration of episodes". As the studies differed in the age of patients and in the baseline values of vertigo, the individual reductions of number, intensity and duration of episodes were adjusted on equal age and baseline values (total means). An analysis of variance (with studies as random effects) showed no relevant influence of studies on the adjusted reductions and no relevant interaction between studies and treatment effects. The meta-analysis of all four trials showed equivalent reductions with VH and with control treatment: mean reduction of the number of daily episodes 4.0 for VH and 3.9 for control (standard error 0.11 for both groups); mean reduction of the duration (on a scale 0-4) for VH 1.1 and for the control 1.0 (standard error 0.03 for both groups); mean reduction of the intensity (on a scale 0-4) for VH 1.18 and for the control 1.8 (standard error 0.03 for both groups). In the non-inferiority analysis from all trials, VH was non-inferior in all variables. The results show the applicability of meta-analyses on the data from studies with homeopathicdrugs and support the results from the individual studies indicating good efficacy and tolerability of VH in patients with vertigo.


Subject(s)
Materia Medica/therapeutic use , Minerals/therapeutic use , Picrotoxin/therapeutic use , Plant Extracts/therapeutic use , Vertigo/drug therapy , Betahistine/adverse effects , Betahistine/therapeutic use , Dimenhydrinate/adverse effects , Dimenhydrinate/therapeutic use , Drug Combinations , Ginkgo biloba , Histamine Agonists/adverse effects , Histamine Agonists/therapeutic use , Humans , Materia Medica/adverse effects , Minerals/adverse effects , Patient Satisfaction , Picrotoxin/adverse effects , Plant Extracts/adverse effects , Randomized Controlled Trials as Topic , Treatment Outcome
7.
Vet Hum Toxicol ; 31(6): 540-3, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2617837

ABSTRACT

Appetoff diet patches were diet aids introduced to the public in 1987 and removed from the market in 1988 by the FDA for reasons of fraud. The ingredients were supposedly homeopathic concentrations of plant and mineral products. Although 91.6% of persons in this study who used the product for at least 1 week reported weight loss and mild side effects, no active ingredients could be detected by gas chromatography/mass spectrometry.


Subject(s)
Appetite Depressants , Administration, Cutaneous , Adult , Appetite Depressants/adverse effects , Appetite Depressants/analysis , Female , Homeopathy , Humans , Interviews as Topic , Male , Middle Aged , Minerals/adverse effects , Nonprescription Drugs/adverse effects , Plants, Medicinal , United States , United States Food and Drug Administration
SELECTION OF CITATIONS
SEARCH DETAIL